Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 698 34 658.0 |
96 | EP file number | EAKZ | 98 96 2011.7 |
86 | WO file number | WAKZ | PCT/US98/26096 |
97 | EP publication number | EPN | 1039887 |
87 | WO publication number | WPN | 1999029312 |
54 | Designation/title | TI | VERWENDUNG VON AMINOTHIOLVERBINDUNGEN ZUR BEHANDLUNG VON NERVEN- UND NIEREN-ERKRANKUNGEN UND DER ARZNEIMITTELTOXIZITÄT |
51 | IPC main class | ICM (ICMV) | A61K 31/095 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/16 (2006.01) |
22 | DE application date | DAT | Dec 9, 1998 |
96 | EP application date | EAT | Dec 9, 1998 |
86 | WO application date | WAT | Dec 9, 1998 |
43 | Date of first publication | OT | Jun 17, 1999 |
| Date of publication of grant | PET | May 24, 2006 |
71/73 | Applicant/owner | INH | Medimmune Oncology, Inc., West Conshohocken, Pa., US; The Arizona Board of Regents, Tucson, Arizona, US |
72 | Inventor | IN | STOGNIEW, Martin, Blue Bell, PA 19422, US; ALBERTS S., David, Tucson, AZ 85711, US; KAPLAN H., Edward, Skokie, IL 60076, US |
74 | Representative | VTR | bohmann, 80335 München, DE |
10 | Published DE documents | DEPN | Original document:
DE000069834658T2 Searchable text:
DE000069834658T2 |
| Address for service | | Anwaltssozietät Bohmann, 80335 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 987550 Dec 9, 1997
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
| Published EP/WO documents | EPWOPN | Original document:
EP000001039887 Searchable text:
EP000001039887 Original document:
EP000001039887B1 Searchable text:
EP000001039887B1 Original document:
WO001999029312 Searchable text:
WO001999029312 |
43 | Date of first publication | EVT | Jun 17, 1999 |
| Date of the first transfer into DPMAregister | EREGT | Sep 28, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 24, 2018 (Show all update days)(Hide all update days)- Oct 24, 2018; Sep 29, 2016; Aug 17, 2016; Oct 23, 2015; Mar 27, 2015; Jan 22, 2015; Jan 9, 2015; Jan 18, 2014; Jan 9, 2014; Feb 2, 2013; Jan 9, 2013
- Historical data not available for this/these date(s)
- Sep 28, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 7)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Apr 19, 2006 |
71/73 | Applicant/owner | INH | Medimmune Oncology, Inc., West Conshohocken, Pa., US; The Arizona Board of Regents, Tucson, Arizona, US |
71/73 | Previous applicant/owner | INHF | U.S. Bioscience, Inc., West Conshohocken, Pa., US, Arizona Board of Regents, Tucson, Ariz., US |